Tickerplace logo

Tickerplace

Top Overvalued Healthcare Sector Stocks 2026

Revolution Medicines, (RVMD) has the largest fair value gap in the Healthcare sector at 99.4% above the modeled estimate, followed by Forte Biosciences, (FBRX) at 99.3%, Oruka Therapeutics, (ORKA) at 99.1%, and Centessa Pharmaceuticals (CNTA) at 98.8%.

Updated todayBased on intrinsic value modelsSector: Healthcare

Page snapshot: 7 Oct 2026, 4:19 pm

View full analysis in the screener → · All overvalued sectors →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Compare price vs fair valueSee intrinsic value →

Healthcare Sector Valuation Insights (Updated Today)

  • The Healthcare sector currently shows an average fair value gap of 87.9% on this snapshot.
  • Top name Revolution Medicines, Inc. (RVMD) trades at roughly a 99.4% gap versus modeled intrinsic value—rankings move with prices and inputs.
  • This sector’s average fair value gap is below our broad benchmark (~94.6%).

Overvalued Healthcare Stocks by Market Cap

Large cap (top 5)

  1. 1.Revolution Medicines, Inc. · RVMD99.4%$42.49B
  2. 2.Summit Therapeutics Inc. · SMMT97.9%$13.81B
  3. 3.Twist Bioscience Corporation · TWST90.6%$10.4B
  4. 4.Roivant Sciences Ltd. · ROIV80.9%$25.67B
  5. 5.Tenet Healthcare Corporation · THC79.7%$20.81B

Mid cap (top 5)

  1. 1.Oruka Therapeutics, Inc. · ORKA99.1%$4.84B
  2. 2.Centessa Pharmaceuticals plc · CNTA98.8%$6.27B
  3. 3.Spyre Therapeutics, Inc. · SYRE98.7%$6.96B
  4. 4.Cogent Biosciences, Inc. · COGT97.7%$5.19B
  5. 5.Pulse Biosciences, Inc. · PLSE97.6%$3.44B

Small cap (top 5)

  1. 1.Forte Biosciences, Inc. · FBRX99.3%$1.58B
  2. 2.Tourmaline Bio, Inc. · TRML97.5%$1.23B
  3. 3.Eton Pharmaceuticals, Inc. · ETON95.0%$1.5B
  4. 4.Zenas BioPharma, Inc. · ZBIO88.9%$1.7B
  5. 5.Stoke Therapeutics, Inc. · STOK80.6%$1.57B

What Are Overvalued Healthcare Stocks?

They are Healthcare companies where the share price sits above modeled intrinsic (fair) value—shown as a fair value gap versus the current quote.

This screen ranks names by fair value gap on our snapshot; it is not a recommendation and models can disagree—always validate on the company page.

How We Identify Overvalued Healthcare Stocks

We combine a live overvalued feed for this sector with price and market-cap context. The fair value gap is expressed versus modeled intrinsic value; rankings can change as inputs move.

Rankings can shift intraday as prices move. Use the stock screener for custom filters beyond this sector leaderboard.

FAQs

Answers about overvalued healthcare names, intrinsic value, and how often this list refreshes.

What are overvalued healthcare stocks?

Overvalued healthcare stocks are Healthcare companies whose market prices sit above modeled intrinsic (fair) value—shown as a fair value gap versus price. The gap is model-dependent and can change quickly; it is a screen, not a recommendation.

How do you find overvalued healthcare stocks?

We pull a live Healthcare list ranked by fair value gap, then show price, market cap, and country context. Use column sorts on the table and company pages to validate fundamentals before acting.

Is this healthcare list a recommendation to buy or sell?

No. The table ranks Healthcare names by calculated gap versus a model. A premium can reflect growth expectations, sentiment, or stale inputs. Review financials and seek licensed advice for personal decisions.

Why are some healthcare stocks overvalued?

Common drivers include sentiment, earnings revisions, sector rotation, rates, and idiosyncratic news. Models may also disagree—treat the fair value gap as one input alongside quality and risk.

How often is this list updated?

This page is rebuilt on a schedule (typically hourly) from our servers. Prices and model inputs can move intraday—open a company page for the latest detail.

Data updated regularly. Intrinsic value estimates and stock prices are subject to market fluctuations.